Neuronal influence behind the central nervous system regulation of the immune cells
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Central nervous system (CNS) has a highly specialized microenvironment, and despite being initially considered an immune privileged site, this immune status is far from absolute because it varies with age and brain topography. The brain monitors immune responses by several means that act in parallel; one pathway involves afferent nerves (vagal nerve) and the other resident cells (neurons and glia). These cell populations exert a strong role in the regulation of the immune system, favoring an immune-modulatory environment in the CNS. Neurons control glial cell and infiltrated T-cells by contact-dependent and -independent mechanisms. Contact-dependent mechanisms are provided by several membrane immune modulating molecules such as Sema-7A, CD95L, CD22, CD200, CD47, NCAM, ICAM-5, and cadherins; which can inhibit the expression of microglial inflammatory cytokines, induce apoptosis or inactivate infiltrated T-cells. On the other hand, soluble neuronal factors like Sema-3A, cytokines, neurotrophins, neuropeptides, and neurotransmitters attenuate microglial and/or T-cell activation. In this review, we focused on all known mechanism driven only by neurons in order to control the local immune cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · cited 2×
“CX3CL1 can be found membrane-anchored or secreted both in physiological and pathological conditions such as facial motor nerve axotomy or a toxic model of Parkinson’s disease (Harrison et al., 1998; Cardona et al., 2006).”
BackgroundCytokines and the central nervous system
Szelényi, J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00428-2 · Cited by 358 · cited 1×
“Both cytokines and their receptors are expressed by neurons and glial cells throughout the CNS (Szelényi, 2001).”
BackgroundFas ligand/Fas system in the brain: regulator of immune and apoptotic responses
Choi, C., & Benveniste, E. N. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.007 · Cited by 270
Hughes, P. M., Botham, M. S., Frentzel, S., Mir, A., & Perry, V. H. (2002) · Glia · doi:10.1002/glia.10037 · Cited by 252 · cited 1×
“The expression of chemokine CX3CL1 (fractalkine) and its receptor CX3CR1 is limited to neurons and microglia, respectively (Hughes et al., 2002).”
BackgroundGyoneva, S., & Traynelis, S. F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.458901 · Cited by 204 · cited 1×
“Moreover, NE regulates microglia morphology and motility by microglial processes retraction; in this dynamic process the β2 and α2A receptors are involved in resting cells and activated microglia cells, respectively (Gyoneva and Traynelis, 2013).”
BackgroundZhang, S., Wang, X.-J., Tian, L.-P., Pan, J., Lu, G.-Q., Zhang, Y.-J., Ding, J.-Q., & Chen, S.-D. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-154 · Cited by 154 · cited 1×
“Also, defects in CD200-CD200R pathway play a critical role in neurodegenerative disease development such as multiple sclerosis (MS), Parkinson’s and Alzheimer’s diseases (Koning et al., 2007; Walker et al., 2009; Zhang et al., 2011).”
BackgroundInterleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-κB
Heyen, J. R. R., Ye, S.-M., Finck, B. N., & Johnson, R. W. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00042-5 · Cited by 146 · cited 1×
“These regulatory molecules down-regulate microglia inhibiting the expression of MHCII, pro-inflammatory cytokines such as TNFα and IL1β, as well as NO synthesis after LPS activation (Suzumura et al., 1993; Sawada et al., 1999; Heyen et al., 2000).”
BackgroundLyons, A., McQuillan, K., Deighan, B. F., O’Reilly, J.-A., Downer, E. J., Murphy, A. C., Watson, M., Piazza, A., O’Connell, F., Griffin, R., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.05.060 · Cited by 98 · cited 1×
“Moreover, IL4 mediated neuronal CD200 expression maintains microglia in a quiescent state and anti-inflammatory/neuroprotective profile (Lyons et al., 2009).”
BackgroundChang, R. C. C., Hudson, P., Wilson, B., Haddon, L., & Hong, J.-S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02255-6 · Cited by 68 · cited 2×
“NCAM also modulates microglial activation, decreases the production of TNFα and nitric oxide (NO) after glial stimulation with lipopolysaccharide (LPS) by reducing the expression of transcription factors like c-Jun, among others (Chang et al., 2000a,b).”
Background
Cited by
Inflammation in neurodegenerative diseases—An update
Amor, S., Peferoen, L. A. N., Vogel, D. Y. S., Breur, M., van der Valk, P., Baker, D., & van Noort, J. M. (2014) · Immunology · doi:10.1111/imm.12233 · Cited by 550
Cuenca, N., Fernández-Sánchez, L., Campello, L., Maneu, V., De la Villa, P., Lax, P., & Pinilla, I. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.07.001 · Cited by 401
Evidence supporting an altered immune response in ASD
Mead, J., & Ashwood, P. (2015) · Immunology Letters · doi:10.1016/j.imlet.2014.11.006 · Cited by 165
A perspective on the role of class III semaphorin signaling in central nervous system trauma
Mecollari, V., Nieuwenhuis, B., & Verhaagen, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00328 · Cited by 79
Senescence in aging and disorders of the central nervous system
Swenson, B. L., Meyer, C. F., Bussian, T. J., & Baker, D. J. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.01.002 · Cited by 24
Metadata
- Authors
- Chavarría, A., & Cárdenas, G.
- Venue
- Frontiers in Integrative Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 7
- Pages
- 64-64
- ISSN
- 1662-5145 (ISSN-L)
- OpenAlex
- W1988777271
- Cited by
- 40
- References
- 9
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.